Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Myelodysplastic Syndromes Clinical Trials
Myelodysplastic Syndromes clinical trials are recruiting across 68 cities. Here are the cities with the most active studies:
Myelodysplastic Syndromes Trial Phases
30 research organizations are sponsoring myelodysplastic syndromes trials.
About Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature properly. MDS can progress to acute myeloid leukemia. Treatments include growth factors, chemotherapy, and stem cell transplant.
Clinical trials are advancing new treatments for myelodysplastic syndromes. Currently, 40 studies are recruiting a combined 5,027 participants across the United States. Research is being conducted by 30 organizations including National Cancer Institute (NCI), Takeda, Chordia Therapeutics, Inc. and 27 others.
2026 Myelodysplastic Syndromes Research Landscape
As of July 2026, the myelodysplastic syndromes clinical trial landscape includes 40 actively recruiting studies across 68 cities in the United States. These studies are collectively seeking 5,027 participants, with an average enrollment target of 126 per study.
The research spans multiple phases of development: 21 studies are in PHASE1, 19 studies are in PHASE2, 3 studies are in PHASE3, 2 studies are in EARLY_PHASE1. The presence of Phase 3 trials indicates that some myelodysplastic syndromes treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 30 different organizations, including National Cancer Institute (NCI), Takeda, Chordia Therapeutics, Inc., Washington University School of Medicine, Syntrix Biosystems, Inc., and 25 others. The large number of sponsors reflects significant research interest and investment in myelodysplastic syndromes treatment advancement.
Geographically, myelodysplastic syndromes trials are most concentrated in Houston, Texas (12 trials); Miami, Florida (7 trials); Duarte, California (6 trials); Tampa, Florida (6 trials); New Haven, Connecticut (5 trials) and 7 other cities.
Featured Myelodysplastic Syndromes Studies
Highlighted recruiting studies for myelodysplastic syndromes, selected by enrollment size and research scope.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
Background: Myelodysplastic syndromes (MDS) occur when the cells that make blood cells are abnormal. There are limited treatment options for MDS. Researchers want to learn more through this natural history study so they can develop better treatments. Objective: To study the natural course of MDS and MDS/myeloproliferative neoplasms (MPN) and collect biological samples that can help researchers ...
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
Background: Myelodysplastic syndromes (MDS) are disorders of blood stem cells that can develop into blood cancers. Treatment options are limited. To find better treatments, researchers need to better understand how MDS develops. To do that, they must be able to compare biospecimens from people with the disease to those of healthy people. Objective: This study will create a database of biospecim...
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
The main aim of this study is to assess how elritercept works in lowering the need for RBC (red blood cell) transfusions and how safe elritercept is when compared with epoetin alfa. Other aims are to learn if elritercept improves tiredness as reported by participants without needing RBC transfusion compared with epoetin alfa, the RBC transfusion burden and quality of life compared with epoetin alf...
Frequently Asked Questions About Myelodysplastic Syndromes Clinical Trials
Are there myelodysplastic syndromes clinical trials near me?
Yes, there are 40 myelodysplastic syndromes clinical trials currently recruiting across 68+ cities in the United States, including Houston, Texas; Miami, Florida; Duarte, California. Browse the studies above to find one at a location convenient for you.
How do I join a myelodysplastic syndromes clinical trial?
To join a myelodysplastic syndromes clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are myelodysplastic syndromes clinical trials free?
Yes, participation in myelodysplastic syndromes clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of myelodysplastic syndromes treatments are being studied?
Current myelodysplastic syndromes clinical trials are testing a range of approaches across PHASE1 (21 studies), PHASE2 (19 studies), PHASE3 (3 studies), EARLY_PHASE1 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 30 research organizations.
Is it safe to participate in myelodysplastic syndromes clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov